House Resolution 746 is a nonbinding Illinois House resolution urging the Illinois Department of Healthcare and Family Services (HFS) to require Medicaid managed care plans and their pharmacy benefit managers to reimburse pharmacies for covered outpatient prescription drugs at rates no lower than the Illinois Medicaid fee-for-service (FFS) program. The resolution specifically calls for parity in both ingredient-cost reimbursement and the professional dispensing fee, and asks HFS to implement that parity through managed care organization contracts and PBM agreements.
The resolution also directs HFS to monitor and report on the effects of reimbursement parity on pharmacy network participation, patient access to medications, and pharmacy closures, and to evaluate its impact on pharmacy deserts, rural health access, and pharmacist-provided services such as medication counseling, chronic disease support, HIV PrEP/PEP, contraception assessment, and preventive care. The bill is framed as a response to pharmacy closures, reimbursement instability, and concerns that managed care payment rates can fall below FFS benchmarks, especially in rural and underserved areas.
Impact
Because HR0746 is a House resolution rather than a statutory amendment, it does not itself change Illinois law or mandate a new reimbursement rule. Its practical effect is to express the House’s policy preference and to encourage HFS to align Medicaid managed care pharmacy payments with the existing Medicaid FFS methodology, potentially influencing future agency contracting, administrative policy, or legislation. If acted upon, the proposal would affect Medicaid managed care organizations, pharmacy benefit managers, community pharmacies, and Medicaid beneficiaries by pushing reimbursement toward a floor tied to state FFS rates.
Sentiment
The overall sentiment in the text is strongly supportive of pharmacy reimbursement parity and favorable to community pharmacies, particularly independent and rural pharmacies. The resolution presents the issue as one of access, transparency, and sustainability, emphasizing that fair reimbursement helps preserve pharmacy networks and patient access to care. No committee transcript or vote record is available, so there is no recorded opposition or formal debate in the provided materials.
Contention
The main policy tension underlying the resolution is between pharmacy advocates seeking reimbursement at or above Medicaid FFS levels and managed care organizations/PBMs that may pay lower rates under negotiated contracts. Supporters argue that below-benchmark reimbursement contributes to pharmacy closures, pharmacy deserts, and reduced access for Medicaid recipients, while the implied counterargument is that higher mandated reimbursement could increase costs or limit contracting flexibility. The resolution also highlights a broader debate over transparency and whether managed care payment arrangements should be tied more closely to state fee-for-service benchmarks.